Introduction

Hepatitis B virus (HBV) has one of the most unusual replication strategies among human DNA viruses.

HBV contains a small, approximately 3.2-kb partially double-stranded circular DNA genome, but unlike conventional DNA viruses, it replicates through an RNA intermediate and reverse transcription. The mature virion contains relaxed circular DNA (rcDNA), which enters the hepatocyte nucleus and is repaired to form covalently closed circular DNA (cccDNA). cccDNA then acts as the long-lived transcriptional template for viral RNA synthesis.

The overall replication cycle can therefore be summarized as:

An equally important alternative pathway is:

Understanding this cycle is essential for understanding HBV persistence, chronic infection, antiviral therapy, drug resistance, and why complete cure remains difficult.

1. The HBV Replication Cycle at a Glance

             INFECTIOUS HBV
             Dane particle
                   │
                   ▼
        Attachment to hepatocyte
                   │
                   ▼
              NTCP binding
                   │
                   ▼
                 Entry
                   │
                   ▼
             Uncoating
                   │
                   ▼
             Nuclear entry
                   │
                   ▼
        rcDNA → cccDNA repair
                   │
                   ▼
              cccDNA
                   │
                   ▼
       Host RNA polymerase II
                   │
                   ▼
        Viral RNA transcription
                   │
             ┌─────┴─────┐
             │           │
             ▼           ▼
          mRNAs        pgRNA
             │           │
             ▼           ▼
       Viral proteins  Core + Pol
                         │
                         ▼
                 pgRNA + Pol
                         │
                         ▼
                 Encapsidation
                         │
                         ▼
                 Reverse transcription
                         │
                         ▼
                       rcDNA
                    ┌────┴────┐
                    │         │
                    ▼         ▼
             cccDNA pool    Envelopment
                              │
                              ▼
                         Dane particle
                              │
                              ▼
                            Release

2. Step 1 — Attachment to the Hepatocyte

HBV replication begins when the infectious virion encounters a susceptible hepatocyte.

Initial attachment involves interactions with cell-surface molecules, including heparan sulfate proteoglycans (HSPGs), followed by the crucial interaction between the viral surface protein and:

Sodium taurocholate cotransporting polypeptide

NTCP

NTCP is encoded by the SLC10A1 gene and is expressed on hepatocytes.

The myristoylated pre-S1 domain of the large surface protein (L-HBs) is particularly important for high-affinity interaction with NTCP.

This interaction is a major determinant of HBV hepatotropism.

3. Step 2 — Viral Entry

After receptor engagement, HBV enters the hepatocyte through an endocytic process involving host-cell machinery.

The precise molecular details of membrane fusion/uncoating remain an active area of research, but the key outcome is:

The nucleocapsid contains:

• HBV rcDNA

• Viral polymerase

• Core protein

4. Step 3 — Intracellular Transport

The nucleocapsid is transported through the cytoplasm toward the nucleus.

The viral genome must ultimately reach the hepatocyte nucleus because the next essential step—formation of cccDNA—occurs there.

The incoming genome is not yet the optimal transcriptional template.

It must first undergo extensive repair.

5. Step 4 — Nuclear Delivery of rcDNA

The viral nucleocapsid delivers:

Relaxed circular DNA (rcDNA)

to the nucleus.

The incoming rcDNA has several unusual structural features:

• The negative strand is essentially complete.

• The positive strand is incomplete.

• Polymerase is covalently attached to the 5′ end of the negative strand.

• An RNA-derived oligonucleotide is attached to the 5′ end of the positive strand.

These features must be removed or repaired before a transcriptionally competent DNA molecule is established.

6. Step 5 — rcDNA → cccDNA

This is one of the most important steps in the entire HBV life cycle.

The incoming rcDNA is converted into:

Covalently closed circular DNA

or:

cccDNA

The process requires host DNA repair machinery.

Broadly, the repair process involves:

1. Removal of polymerase from the negative strand

2. Removal of the RNA primer from the positive strand

3. Completion of the incomplete positive strand

4. Repair of DNA gaps

5. Ligation of DNA ends

6. Formation of covalently closed circular DNA

Host factors implicated in cccDNA formation include DNA repair proteins such as TDP2, DNA polymerases, DNA ligases, FEN1 and topoisomerases, although the complete molecular pathway remains incompletely defined.

7. Why cccDNA Is So Important

cccDNA is the central reservoir of HBV infection.

It is located in the:

Nucleus of the hepatocyte

and exists as a chromatinized episomal DNA molecule.

It acts as the transcriptional template for viral RNA production.

Therefore:

cccDNA persistence is one of the major biological barriers to complete HBV eradication.

8. cccDNA as a Viral Minichromosome

cccDNA associates with:

• Host histones

• Cellular transcription factors

• Other chromatin-associated proteins

It forms a structure often described as an:

HBV cccDNA minichromosome

Its transcriptional activity can be influenced by:

• Epigenetic modifications

• Histone acetylation

• Histone methylation

• Viral proteins

• Host transcription factors

• Immune-mediated effects

Therefore, HBV replication is not simply controlled by the viral genome itself; it is closely integrated with host nuclear biology.

9. Step 6 — Transcription From cccDNA

Once cccDNA has been established, the host cell's:

RNA polymerase II

transcribes viral RNA.

This is an important point:

Instead, it uses the host transcriptional machinery.

The resulting RNAs are capped and polyadenylated and serve as templates for viral protein synthesis and genome replication.

10. Major HBV RNA Transcripts

The major transcripts include:

1. Pregenomic RNA

pgRNA

Approximately 3.5 kb.

2. Precore RNA

Also approximately 3.5 kb but with a different 5′ start site.

3. 2.4-kb RNA

Predominantly associated with:

L-HBs

4. 2.1-kb RNAs

Associated with:

• M-HBs

• S-HBs

5. ~0.7-kb RNA

Associated with:

HBx

11. Pregenomic RNA — The Central RNA

The most important transcript in HBV replication is:

Pregenomic RNA

or:

pgRNA

It performs two major functions.

Function 1 — mRNA

It is translated to produce:

• Core protein

• Polymerase

Function 2 — Template for reverse transcription

It is packaged into the nucleocapsid and converted into viral DNA.

Therefore:

This dual function is one of the defining characteristics of HBV replication.

12. Why Is pgRNA Longer Than the Genome?

The HBV genome is approximately:

3.2 kb

but pgRNA is approximately:

3.5 kb

The pgRNA contains:

Terminal redundancy

of approximately 120 nucleotides.

This redundancy contains important sequences involved in reverse transcription, including repeated elements associated with:

• DR1

• ε

This arrangement is essential for the strand-transfer reactions required to regenerate circular DNA.

13. Translation of Viral Proteins

Viral RNAs are exported to the cytoplasm and translated by host ribosomes.

Important proteins produced include:

From S region

• L-HBs

• M-HBs

• S-HBs

From C/pre-C region

• HBcAg

• HBeAg

From P region

• Polymerase

From X region

• HBx

The surface proteins enter the endoplasmic reticulum and are ultimately incorporated into viral envelopes.

14. Step 7 — Translation of Core Protein

Core protein is translated from pgRNA.

Core protein molecules assemble into:

Capsid/core protein dimers

These form the structural basis of the nucleocapsid.

Core protein is therefore essential for selectively packaging the replication complex.

15. Step 8 — Translation of Polymerase

The HBV polymerase is translated from pgRNA.

It contains multiple functional regions:

1. Terminal protein (TP)

2. Spacer

3. Reverse transcriptase/DNA polymerase

4. RNase H

The polymerase is the enzyme responsible for converting the RNA genome intermediate back into DNA.

16. Step 9 — Formation of the Polymerase–pgRNA Complex

A critical cis-acting RNA element within pgRNA is:

ε (epsilon)

It forms a characteristic stem-loop structure.

HBV polymerase recognizes ε.

The interaction between:

is a critical initiating event for both:

• pgRNA encapsidation

• Reverse transcription

17. The ε Packaging Signal

ε is located near the:

5′ end of pgRNA

It is a structured RNA element rather than simply a linear nucleotide sequence.

It functions as:

Packaging signal

and

Reverse-transcription initiation signal

The polymerase–ε interaction recruits the pgRNA and polymerase into the developing nucleocapsid.

18. Step 10 — Encapsidation

The pgRNA–polymerase complex is selectively packaged into newly forming core particles.

Core protein assembles around the complex.

The result is:

Immature nucleocapsid

containing:

• pgRNA

• Polymerase

• Core protein

The capsid therefore provides a specialized intracellular environment for reverse transcription.

19. Why Reverse Transcription Occurs Inside the Capsid

HBV reverse transcription occurs predominantly within the protected nucleocapsid.

This provides:

• A controlled environment

• Protection of replication intermediates

• Spatial organization of polymerase and pgRNA

• Coordination between genome synthesis and capsid maturation

Thus the nucleocapsid is not merely a packaging structure.

It is effectively a:

20. Step 11 — Initiation of Reverse Transcription

The first DNA synthesis event is unusual.

HBV polymerase uses its:

Terminal protein domain

as a protein primer.

A tyrosine residue within the terminal protein domain becomes covalently linked to the nascent DNA.

The ε RNA structure provides the template for the first few nucleotides.

Approximately 3–4 nucleotides are initially synthesized.

21. Protein-Primed DNA Synthesis

Most DNA polymerases use a nucleic acid primer.

HBV polymerase instead uses:

Protein priming

The polymerase itself provides the primer through a specific tyrosine residue.

This is an unusual and highly characteristic feature of hepadnaviral replication.

Conceptually:

Polymerase–Tyr-OH

↓

first dNMP attached

↓

short DNA primer

↓

DNA elongation

22. Step 12 — First Strand Transfer

The short DNA primer initially synthesized using ε must be transferred to:

DR1

near the 3′ end of pgRNA.

This is the first major template-switching event.

The complementary sequences allow the nascent minus-strand DNA to pair with the appropriate DR1 region.

This permits continued synthesis of the negative DNA strand.

23. Step 13 — Minus-Strand DNA Synthesis

The viral polymerase now extends the:

Negative DNA strand

using pgRNA as the template.

The negative strand becomes essentially full length.

During this process, the RNA template is progressively degraded by the polymerase's:

RNase H activity

24. RNase H Activity

The HBV polymerase therefore performs two related functions during this stage:

Reverse transcriptase

RNA → DNA

and

RNase H

RNA degradation within RNA-DNA hybrids.

As minus-strand DNA synthesis progresses:

pgRNA template

↓

RNA-DNA hybrid

↓

RNase H degradation

↓

largely RNA-free negative DNA strand

25. The Residual RNA Primer

The RNase H activity does not simply destroy every RNA nucleotide.

A short RNA fragment remains.

This residual RNA acts as the primer for:

Positive-strand DNA synthesis

This is another elegant feature of the HBV replication mechanism.

26. Step 14 — Second Strand Transfer

The remaining RNA primer is transferred to:

DR2

on the newly synthesized negative DNA strand.

This is another critical template-switching event.

The primer then initiates synthesis of:

Positive-strand DNA

27. Step 15 — Positive-Strand DNA Synthesis

The polymerase extends the positive strand using the negative DNA strand as template.

However, positive-strand DNA synthesis is generally incomplete by the time the nucleocapsid matures and is released.

This explains why the mature HBV genome is:

Partially double-stranded

28. Formation of rcDNA

The final product is:

Relaxed circular DNA

or:

rcDNA

It consists of:

• Nearly complete negative strand

• Incomplete positive strand

• Polymerase attached to the negative strand

• RNA-derived primer associated with the positive strand

This is the genome packaged into the mature HBV virion.

29. Why Is It Called “Relaxed Circular”?

It is circular but not covalently closed.

The two strands are not completely paired across their entire lengths.

Therefore:

This distinction is fundamental.

30. rcDNA vs cccDNA

31. Step 16 — Fate of the Mature Nucleocapsid

Once rcDNA synthesis is sufficiently advanced, the nucleocapsid becomes mature.

It has two principal fates.

Pathway A — Intracellular recycling

The nucleocapsid returns to the nucleus.

Pathway B — Envelopment

The nucleocapsid interacts with HBV surface proteins and becomes enveloped.

32. Pathway A — cccDNA Amplification

Some mature nucleocapsids deliver their rcDNA back to the nucleus.

The rcDNA can again be converted to:

cccDNA

This contributes to maintenance or amplification of the nuclear cccDNA pool.

This intracellular recycling pathway is important for establishing and maintaining HBV infection.

33. Pathway B — Envelopment

Other mature nucleocapsids acquire an envelope containing:

• L-HBs

• M-HBs

• S-HBs

The process occurs through interactions with intracellular membrane systems, particularly the endoplasmic reticulum-associated secretory pathway.

The resulting particle is:

Mature infectious HBV virion

34. Step 17 — Virion Secretion

Mature HBV particles are transported through the secretory pathway and released from the hepatocyte.

The extracellular infectious particle is:

Dane particle

approximately:

42 nm

It contains:

• Lipid envelope

• HBs proteins

• Core

• rcDNA

• Polymerase

35. Production of Subviral Particles

HBV does not only release complete virions.

It produces enormous quantities of:

HBsAg subviral particles

These include:

• Spherical particles

• Filamentous particles

They lack the complete nucleocapsid/genome and are therefore non-infectious.

This explains why circulating HBsAg can be present in huge excess over infectious HBV particles.

36. The Complete Replication Cycle

The entire process can now be summarized:

Phase 1 — Entry

HBV → hepatocyte

↓

NTCP

↓

entry

Phase 2 — Nuclear establishment

rcDNA

↓

DNA repair

↓

cccDNA

Phase 3 — Transcription

cccDNA

↓

RNA polymerase II

↓

viral RNAs

Phase 4 — Protein synthesis

viral mRNAs

↓

viral proteins

Phase 5 — Genome replication

pgRNA + polymerase

↓

ε recognition

↓

encapsidation

↓

reverse transcription

↓

rcDNA

Phase 6 — Virion production

rcDNA nucleocapsid

↓

envelopment

↓

Dane particle

↓

release

37. Three Critical Molecular Conversions

HBV replication becomes much easier if you remember three conversions:

Conversion 1

rcDNA → cccDNA

Occurs in the nucleus.

Conversion 2

cccDNA → pgRNA

Occurs through host RNA polymerase II transcription.

Conversion 3

pgRNA → rcDNA

Occurs through viral reverse transcription inside the nucleocapsid.

Therefore:

This is the central molecular cycle of HBV.

38. Why HBV Is Called a Reverse-Transcribing DNA Virus

The mature virion contains:

DNA

but during replication the virus produces:

RNA

and then converts:

RNA → DNA

Therefore:

DNA → RNA → DNA

This is the defining replication strategy of HBV.

39. HBV vs Retrovirus

HBV and retroviruses both use reverse transcription, but they are not the same.

A crucial distinction:

40. HBV Reverse Transcription vs Cellular DNA Replication

HBV reverse transcription is unusual because:

• It occurs inside a capsid.

• It begins with protein priming.

• It uses RNA as template.

• The polymerase has RNase H activity.

• Strand transfers are required.

• The final DNA is only partially double-stranded.

41. Important Role of DR1 and DR2

The HBV genome contains direct repeats:

DR1

and

DR2

These sequences participate in template switching.

They allow the short nascent DNA primer to move between complementary regions during reverse transcription.

Without these strand-transfer mechanisms, formation of the characteristic circular HBV DNA genome would not occur.

42. Role of ε in Replication

The ε structure has two major functions:

1. Encapsidation

It recruits polymerase and directs selective packaging of pgRNA.

2. Reverse transcription initiation

It provides the template for protein-primed DNA synthesis.

Thus:

43. Role of Core Protein

Core protein is not simply structural.

It participates in:

• Capsid assembly

• pgRNA encapsidation

• Polymerase packaging

• Reverse transcription environment

• Nucleocapsid maturation

• Intracellular trafficking

Therefore:

44. Role of Polymerase

The HBV polymerase is multifunctional.

One viral protein therefore performs several steps of genome replication.

45. Replication and Genetic Variability

HBV polymerase lacks the high-fidelity proofreading system characteristic of many cellular DNA polymerases.

Therefore reverse transcription generates genetic variation.

This produces a population of closely related viral variants:

HBV quasispecies

Selection pressures include:

• Host immune response

• Antiviral drugs

• Vaccination-related immune pressure

• Changes in the cellular environment

This contributes to:

• Immune escape

• Drug resistance

• HBeAg-negative variants

• Diagnostic escape variants

46. Replication and Drug Resistance

Because polymerase is essential for:

pgRNA → DNA

drugs targeting polymerase can strongly suppress HBV replication.

Important modern nucleos(t)ide analogues include:

• Tenofovir disoproxil fumarate

• Tenofovir alafenamide

• Entecavir

They inhibit viral DNA synthesis.

However:

Therefore viral suppression can occur without complete eradication.

47. Why Antiviral Therapy Does Not Immediately Cure HBV

Suppose:

Serum HBV DNA ↓↓↓

This indicates strong suppression of productive viral replication.

However:

cccDNA remains

↓

Potential transcriptional activity persists.

Furthermore:

Integrated HBV DNA may remain

↓

HBsAg production may continue in some patients.

Therefore:

48. cccDNA and Chronic Infection

Persistent cccDNA is central to chronic HBV infection.

Its persistence allows:

• Continued viral RNA transcription

• Production of new virions

• Replenishment of intracellular cccDNA

• Reactivation when immune control is lost

This is particularly important during:

• Immunosuppressive therapy

• Chemotherapy

• Organ transplantation

• Certain immunomodulatory treatments

49. HBV Replication and Reactivation

A patient with previously controlled or apparently resolved HBV infection may experience:

HBV reactivation

when immune surveillance is significantly reduced.

The underlying biology involves persistence of HBV genetic material, particularly cccDNA and/or other viral DNA forms.

Therefore, patients at risk may require:

• HBV screening

• HBV DNA monitoring

• Antiviral prophylaxis or therapy

depending on the clinical setting.

50. Replication and HBsAg

HBsAg can arise from:

Productive HBV replication

and, importantly:

Integrated HBV DNA

Therefore:

This is another reason why HBV DNA is important for assessing active viral replication.

51. Replication and HBeAg

HBeAg is generally associated with active replication and higher infectivity.

However:

Precore mutations

and:

Basal core promoter mutations

may result in:

HBeAg-negative but HBV-DNA-positive infection.

Therefore, viral replication must ultimately be assessed using:

HBV DNA

rather than HBeAg alone.

52. Replication — Major Checkpoints

53. Replication Cycle — High-Yield Flowchart

HBV Dane particle
       ↓
HSPG attachment
       ↓
NTCP binding
       ↓
Entry into hepatocyte
       ↓
Nucleocapsid trafficking
       ↓
Nuclear entry
       ↓
rcDNA
       ↓
Host DNA repair
       ↓
cccDNA
       ↓
RNA Pol II
       ↓
Viral RNA
       ↓
pgRNA
       ↓
Core + Polymerase
       ↓
P–ε interaction
       ↓
pgRNA encapsidation
       ↓
Protein-primed reverse transcription
       ↓
(-) DNA synthesis
       ↓
RNase H degradation of pgRNA
       ↓
(+) DNA synthesis
       ↓
rcDNA
       ↓
 ┌───────────────┴───────────────┐
 ↓                               ↓
Nuclear recycling            Envelopment
 ↓                               ↓
cccDNA amplification        Dane particle
                                 ↓
                              Release

54. The Most Important Examination Question

Why does HBV have a partially double-stranded DNA genome if it replicates through RNA?

Because:

1. cccDNA produces pgRNA.

2. pgRNA is encapsidated.

3. Polymerase reverse-transcribes pgRNA into negative DNA.

4. The RNA template is degraded.

5. Positive DNA synthesis begins.

6. Positive-strand synthesis remains incomplete at virion maturation.

Therefore the mature genome becomes:

55. The Most Important Clinical Question

Why can HBV persist despite potent antiviral therapy?

Because nucleos(t)ide analogues primarily inhibit:

but do not directly eliminate:

Therefore:

Polymerase inhibition ≠ cccDNA eradication

This distinction explains the need for prolonged therapy in many patients with chronic HBV.

56. Five Must-Know HBV Replication Facts

1.

HBV enters hepatocytes primarily through:

NTCP

2.

Incoming genome:

rcDNA

3.

Nuclear reservoir:

cccDNA

4.

Replication intermediate:

pgRNA

5.

Genome synthesis:

pgRNA → rcDNA by reverse transcription

57. One-Line Memory Trick

Remember:

RC = rcDNA enters the nucleus

CC = cccDNA stays in the nucleus

RNA = viral RNA/pgRNA is produced

DNA = reverse transcription regenerates rcDNA

58. Final Concept

HBV replication is a continuous molecular cycle:

The key feature is the separation of the cycle into two cellular compartments:

Nucleus

rcDNA → cccDNA → transcription

Cytoplasm/nucleocapsid

pgRNA → reverse transcription → rcDNA

The virus then decides between two fates:

rcDNA-containing nucleocapsid → nucleus

to maintain/amplify cccDNA,

or:

rcDNA-containing nucleocapsid → envelope → extracellular virion.

This elegant but unusual life cycle explains virtually everything that follows in HBV microbiology:

cccDNA → chronicity

polymerase → antiviral target

reverse transcription → genetic variability

ε + DR1/DR2 → genome replication

NTCP → hepatotropism

integrated DNA/cccDNA → persistence

immune pressure + replication → HBV mutants

Standard References

1. Knipe DM, Howley PM, editors. Fields Virology. Wolters Kluwer.

2. Flint SJ, Enquist LW, Racaniello VR, Rall GF. Principles of Virology. ASM Press.

3. Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology. Elsevier.

4. Brooks GF, Carroll KC, Butel JS, Morse SA, Mietzner TA. Jawetz, Melnick & Adelberg's Medical Microbiology. McGraw-Hill.

5. Ryan KJ, Ray CG. Sherris Medical Microbiology. McGraw-Hill.

6. Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier.

7. Seeger C, Mason WS. Hepatitis B virus biology. Microbiology and Molecular Biology Reviews.

8. Seeger C, Zoulim F, Mason WS. Hepadnaviruses. In: Fields Virology.

9. Locarnini S, Zoulim F. Molecular genetics of HBV and antiviral resistance.

10. Yan H, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife. 2012.

11. Nassal M. Hepatitis B virus replication: novel roles of an enigmatic enzyme. Journal of Hepatology.

12. Ganem D, Prince AM. Hepatitis B virus infection—natural history and clinical consequences. New England Journal of Medicine.

13. World Health Organization. Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. WHO; 2024.

14. Seeger C, Mason WS. Molecular biology of hepatitis B virus infection.

15. DNA Engineering and Hepatitis B Virus Replication. Review of HBV encapsidation, ε-mediated priming and reverse transcription.

16. Hepatitis B Virus Epsilon (ε) RNA Element: Dynamic Regulator of Viral Replication and Attractive Therapeutic Target.